Recall record at a glance
| Official record | F-1397-2018 |
|---|---|
| Category | Food Recalls |
| Classification | Class III |
| FDA record status | Terminated |
| Recalling firm | Sugarfina, LLC |
| Report date | May 16, 2018 |
| Recall initiation date | Apr 11, 2018 |
| Quantity | 1,342 units |
| Location | Inglewood, CA, United States |
Official product description
Sugarfina Platinum Bling Ring; Product SKU No. R-1790 UPC: 840278116139 Net W. 21g ().7 oz.) Sculpted from dark chocolate, these interlocking rings have a thin sugar shell brushed with edible silver: Ingredients: Dark Chocolate (cocoa, sugar, cocoa butter, soy lecithin (an emulsifier_ sugar, Dextrose, gum Arabic, color added, gelatin. Made in Greece Distributed by Sugarfina Inc. Santa Monica Blvd., Beverly Hills, CA
Why the product was recalled
Internal audit discovered that their Platinum Bling Ring product contains fish gelatin that is not declared on the ingredient or allergen information
Distribution information
FL, AR, OR, UT, PA, CA, NJ, MA,NY, MD, IL, IN,SC, TN, LA, GA.
How to read the classification
FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Letter.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.